Gyre Therapeutics, Inc.
GYREAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
Earnings History
Next report: Mar 11, 2027 · EPS est. $-0.16| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Nov 5, 2026 | $0.04 | $-0.15 | $32.9M | $28.4M |
| Aug 7, 2026 | $-0.12 | $-0.06 | $29.1M | $26.5M |
| May 7, 2026 | $-0.05 | $-0.06 | $22.5M | $31.6M |
| Mar 12, 2026 | $-0.02 | $0.06 | $37.2M | $35.4M |
| Nov 7, 2025 | $0.06 | $0.05 | $30.6M | $32.9M |
| Aug 11, 2025 | $0.02 | $0.03 | $26.8M | $30.8M |
| May 9, 2025 | $0.03 | $0.03 | $22.1M | $28.4M |
| Mar 17, 2025 | $0.01 | $0.04 | $27.9M | $23.5M |
News
Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $0.06 per share a year ago.
Q3 2026 revenue of $32.9 million; GAAP basic EPS: $(0.04) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed SAN DIEGO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre Therapeutics or the Company) (Nasdaq: GYRE), a U.S. biopharmaceutical company with research operations and commercial business in China to advance global development of protein degrader therapeutics, today announced financial results for the third quarter ended September 30, 2026, and provid…
Gyre Therapeutics (NASDAQ: GYRE - Get Free Report) and Traws Pharma (NASDAQ: TRAW - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of
SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre Therapeutics or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that Company management will participate in the Cantor Global Healthcare Conference and the Morgan Stanley Healthcare Conference, both being held this month in New York, NY.